<DOC>
	<DOCNO>NCT00116363</DOCNO>
	<brief_summary>This research study look way treatment call INGN241 kill melanoma cell help patient 's immune system kill melanoma cell .</brief_summary>
	<brief_title>Safety Efficacy Study INGN 241 Gene Therapy Patients With In Transit Melanoma</brief_title>
	<detailed_description>INGN 241 adenoviral vector carry MDA-7 cDNA . MDA-7 novel tumor suppressor molecule cytokine property , recently designate IL-24 . Over expression MDA-7 melanoma cell vitro show inhibit cellular proliferation induce apoptosis . Loss MDA-7 expression human melanoma show correlate invasion metastasis . The INGN 241 gene transfer construct previously use human subject ongoing open label Phase I study use intratumoral administration , well tolerated date . The primary objective present study determine INGN 241 , inject melanoma transit lesion , induce apoptosis regional uninjected lesion initiate systemic immune activation . Secondary objective include examination specific immunity clinical response toxicity .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Histologically proven melanoma , must 3 regional metastatic lesion transit Central nervous system involvement melanoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>gene therapy</keyword>
	<keyword>melanoma</keyword>
	<keyword>adenovirus</keyword>
	<keyword>in-transit melanoma</keyword>
	<keyword>metastatic melanoma</keyword>
</DOC>